Received Dec 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| FLU3 | INFLUENZA (SEASONAL) (FLUAD) | SEQIRUS, INC. | UNK | — | — |
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
arms are sore; a1c elevated, put me in diabetic range; This is a spontaneous report received from a Consumer or other non HCP and a Physician from License Party. Other Case identifier(s): 2025SA339045 (Sanofi), AE-021897 (BioNTech). A 59-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), in 2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; sarilumab (KEVZARA), since 2025 at 200 mg (200 mg (qow, strength 200mg/1.4ml )) for illness; influenza vaccine inact sag 3v (FLUAD), in 2025 as dose number unknown, single for immunisation; pneumococcal vaccine polysacch 23v (PNEUMOVAX), in 2025 as dose number unknown, single for immunisation; varicella zoster vaccine rge (cho) (SHINGRIX), in 2025 as dose number unknown, single for immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: METHOTREXATE; TAMSULOSIN HYDROCHLORIDE; CHANTIX; PREDNISONE; VITAMIN D3; MULTIVITAMIN [VITAMINS NOS]. The following information was reported: GLYCOSYLATED HAEMOGLOBIN INCREASED (non-serious) with onset 2025, outcome "unknown", described as "a1c elevated, put me in diabetic range"; PAIN IN EXTREMITY (non-serious) with onset 2025, outcome "unknown", described as "arms are sore". Relevant laboratory tests and procedures are available in the appropriate section. The action taken for sarilumab was unknown. Batch/lot number is not provided, and it cannot be obtained.
METHOTREXATE; TAMSULOSIN HYDROCHLORIDE; CHANTIX; PREDNISONE; VITAMIN D3; MULTIVITAMIN [VITAMINS NOS]; KEVZARA
Test Date: 2025; Test Name: A1c; Result Unstructured Data: Test Result:Elevated; Comments: put me in diabetic range